Cargando…

Identifying immune checkpoint-related lncRNA biomarkers for immunotherapy response and prognosis in cancers

Long non-coding RNAs (lncRNAs) could modulate expression of immune checkpoints (ICPs) in tumor-immune. However, precise functions in immunity and potential for predicting ICP inhibitors (ICI) response have been described for only a few lncRNAs. Here, a multiple-step pipeline was developed to identif...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Yue, Wang, Xinyue, Dong, Longlong, Qu, Changfan, Lu, Qianyi, Wang, Peng, Xin, Mengyu, Zheng, Wen, Liu, Chenyu, Ning, Shangwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539355/ https://www.ncbi.nlm.nih.gov/pubmed/37770497 http://dx.doi.org/10.1038/s41597-023-02550-z

Ejemplares similares

Evaluating the utility of an immune checkpoint-related lncRNA signature for identifying the prognosis and immunotherapy response of lung adenocarcinoma
por: Zhang, Hongpan, et al.
Publicado: (2022)

Identifying tumour microenvironment-related signature that correlates with prognosis and immunotherapy response in breast cancer
por: Zhao, Hongying, et al.
Publicado: (2023)

Identification of Potential Biomarkers of Prognosis-Related Long Non-Coding RNA (lncRNA) in Pediatric Rhabdoid Tumor of the Kidney Based on ceRNA Networks
por: Wu, Xiongwei, et al.
Publicado: (2020)

LncRNA PVT1 as an effective biomarker for cancer diagnosis and detection based on transcriptome data and meta-analysis
por: Zeng, Yunhong, et al.
Publicado: (2017)

LncRNA NORAD as a Novel Predictor of Lymph Node Metastasis and Prognosis in Solid Tumors: A Systematic Review and Meta-Analysis
por: Ye, Tao, et al.
Publicado: (2020)

Meta-analysis of the prognostic value of lncRNA ZFAS1 in patients with solid tumors
por: Song, Wei, et al.
Publicado: (2017)

The Clinical Prognostic Value of lncRNA SBF2-AS1 in Cancer Patients: A Meta-Analysis
por: Wang, Jie, et al.
Publicado: (2021)

Identification of immunotherapy-related lncRNA signature for predicting prognosis, immunotherapy responses and drug candidates in bladder cancer
por: Hui, Pengyu, et al.
Publicado: (2023)

Using Immune-Related lncRNA Signature for Prognosis and Response to Immunotherapy in Cutaneous Melanoma
por: Xue, Ling, et al.
Publicado: (2021)

Bioinformatics prediction and experimental verification identify cuproptosis-related lncRNA as prognosis biomarkers of hepatocellular carcinoma
por: Liangyu, Zhu, et al.
Publicado: (2023)

Identifying the Predictive Role of Oxidative Stress Genes in the Prognosis of Glioma Patients
por: Lu, Di, et al.
Publicado: (2021)

A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma
por: Lu, Yinliang, et al.
Publicado: (2022)

Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma
por: Liang, Deku, et al.
Publicado: (2021)

Integrated Analysis of lncRNA-Associated ceRNA Network Identifies Two lncRNA Signatures as a Prognostic Biomarker in Gastric Cancer
por: Zhang, Shuyan, et al.
Publicado: (2021)

The LncRNA signature associated with cuproptosis as a novel biomarker of prognosis in immunotherapy and drug screening for clear cell renal cell carcinoma
por: Zhang, Lishuo, et al.
Publicado: (2023)

Prognostic role of lncRNA TUG1 for cancer outcome: Evidence from 840 cancer patients
por: Liu, Jia, et al.
Publicado: (2017)

Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022)

Construction and Validation of a Ferroptosis-Related lncRNA Signature as a Novel Biomarker for Prognosis, Immunotherapy and Targeted Therapy in Hepatocellular Carcinoma
por: Zhang, Ze, et al.
Publicado: (2022)

Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis
por: Chen, Qiqi, et al.
Publicado: (2022)

LncRNA and its role in gastric cancer immunotherapy
por: Zhang, Qiang, et al.
Publicado: (2023)

LncRNA CRNDE and lncRNA SNHG7 are Promising Biomarkers for Prognosis in Synchronous Colorectal Liver Metastasis Following Hepatectomy
por: Zhang, Peixian, et al.
Publicado: (2020)

Dynamic TF-lncRNA Regulatory Networks Revealed Prognostic Signatures in the Development of Ovarian Cancer
por: Guo, Qiuyan, et al.
Publicado: (2020)

Characterization of lncRNA-Perturbed TLR-Signaling Network Identifies Novel lncRNA Prognostic Biomarkers in Colorectal Cancer
por: Chu, Yanjie, et al.
Publicado: (2020)

Biomarker potential of lncRNA GNAS-AS1 in osteosarcoma prognosis and effect on cellular function
por: Mi, Zhanhu, et al.
Publicado: (2021)

Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma
por: Pang, Yipeng, et al.
Publicado: (2023)

Novel inflammatory biomarkers in the prognosis of COVID-19
por: Zhan, Kegang, et al.
Publicado: (2023)

LIMIT is an immunogenic lncRNA in cancer immunity and immunotherapy
por: Li, Gaopeng, et al.
Publicado: (2021)

Association between long non-coding RNA (lncRNA) GAS5 polymorphism rs145204276 and cancer risk
por: Zhao, Shushan, et al.
Publicado: (2021)

A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma
por: Yu, Sheng, et al.
Publicado: (2023)

Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
por: Zheng, Miao, et al.
Publicado: (2020)

lncRNA PVT1 identified as an independent biomarker for prognosis surveillance of solid tumors based on transcriptome data and meta-analysis
por: Chen, Xiaoliang, et al.
Publicado: (2018)

lncRNA-CCDC26, as a novel biomarker, predicts prognosis in acute myeloid leukemia
por: Chen, Cunte, et al.
Publicado: (2019)

Immune checkpoint inhibitors use and effects on prognosis of COVID-19 infection: a systematic review and meta-analysis
por: Qian, Wenwei, et al.
Publicado: (2021)

LncRNA profile study reveals four-lncRNA signature associated with the prognosis of patients with anaplastic gliomas
por: Wang, Wen, et al.
Publicado: (2016)

A genomic instability-related lncRNA model for predicting prognosis and immune checkpoint inhibitor efficacy in breast cancer
por: Jiao, Ying, et al.
Publicado: (2022)

Systematic analysis of lncRNA–miRNA–mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer
por: Fan, Chun-Ni, et al.
Publicado: (2018)

Quantitative assessment of lncRNA HOTAIR polymorphisms and cancer risk in Chinese population: a meta-analysis based on 26,810 subjects
por: Liu, Xu, et al.
Publicado: (2017)

A seven-lncRNA signature for predicting prognosis in breast carcinoma
por: Xu, Min, et al.
Publicado: (2021)

Comprehensive Characterization of Somatic Mutations Impacting lncRNA Expression for Pan-Cancer
por: Gao, Yue, et al.
Publicado: (2019)

Identification of CD4(+) Conventional T Cells-Related lncRNA Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Breast Cancer
por: Ning, Shipeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hj50a7ajun54kc45manjm5td1d